title: Assessing the risk of measles resurgence in a highly vaccinated population: Belgium anno 2013.
abstract: Despite long-standing two-dose measles-mumps-rubella (MMR) vaccination, measles outbreaks still occur in highly vaccinated European populations. For instance, large measles outbreaks occurred in France (2008–13), the United Kingdom (2012–13) and the Netherlands (2012). Based on a multicohort model approach, using spatial serological survey data, MMR vaccination coverage data and data on social contacts, we found effective reproduction numbers significantly higher than 1 for measles in Belgium. This indicates that at one of the expected re-introductions, a measles outbreak is likely to spread, especially when it occurs during school term. The predicted average effective reproduction number increased over a 30-year time span from 1.3 to 2.2 and from 1.9 to 3.2 for basic reproduction numbers of 12 and 18, respectively. The expected relative measles incidence was highest in infants under one year of age, in adolescents and young adults. In conclusion, gradually increasing proportions of susceptible adolescents and young adults provide through their highly active social life an avenue for measles to resurge in large outbreaks upon re-introduction in Belgium, especially during school terms. Infants form an important vulnerable group during future measles outbreaks.
authors.affiliation: Interuniversity Institute for Biostatistics and statistical Bioinformatics, Hasselt University, Hasselt, Belgium.
authors.forename: N
authors.initials: N
authors.lastname: Hens
authors.forename: S
authors.initials: S
authors.lastname: Abrams
authors.forename: E
authors.initials: E
authors.lastname: Santermans
authors.forename: H
authors.initials: H
authors.lastname: Theeten
authors.forename: N
authors.initials: N
authors.lastname: Goeyvaerts
authors.forename: T
authors.initials: T
authors.lastname: Lernout
authors.forename: E
authors.initials: E
authors.lastname: Leuridan
authors.forename: K
authors.initials: K
authors.lastname: Van Kerckhove
authors.forename: H
authors.initials: H
authors.lastname: Goossens
authors.forename: P
authors.initials: P
authors.lastname: Van Damme
authors.forename: P
authors.initials: P
authors.lastname: Beutels
mesh_terms: D000293:Adolescent; D000367:Age Factors; D001530:Belgium / Q000453:epidemiology; D002648:Child; D002675:Child, Preschool; D004196:Disease Outbreaks / Q000517:prevention & control*; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008457:Measles / Q000453:epidemiology / Q000517:prevention & control*; D022542:Measles-Mumps-Rubella Vaccine / Q000008:administration & dosage; D015233:Models, Statistical; D009426:Netherlands / Q000453:epidemiology; D018570:Risk Assessment; D016036:Seroepidemiologic Studies; D062206:Spatial Analysis; D006113:United Kingdom / Q000453:epidemiology; D014611:Vaccination / Q000706:statistics & numerical data*; D055815:Young Adult
chemical_list: D022542:Measles-Mumps-Rubella Vaccine